Showing results (331-340 of 403) with videos related to

Sort By:
Pageof 41
Cancers|March 4, 2020
Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-AnalysisFausto Petrelli, Diego Signorelli, Michele Ghidini, et al.
The Lancet. Oncology|December 14, 2007
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trialStefano Cascinu, Rossana Berardi, Roberto Labianca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 9, 2003
Pain and its treatment in hospitalized patients with metastatic cancerStefano Cascinu, Paolo Giordani, Romina Agostinelli, et al.
Future Oncology (London, England)|May 7, 2014
Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM studyLaura Orlando, Francesco Giotta, Vito Lorusso, et al.
Cancers|September 3, 2020
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 PandemicAlberto Zaniboni, Michele Ghidini, Francesco Grossi, et al.
Cancers|August 14, 2025
Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective AnalysisMichele Ghidini, Fausto Petrelli, Matteo Paccagnella, et al.
International Journal of Cancer|February 19, 2016
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapyCathy Eng, Alberto Bessudo, Lowell L Hart, et al.
BMC Cancer|February 1, 2023
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant settingXavier Pivot, Alexey Georgievitch Manikhas, Volodymyr Shamrai, et al.
Clinical Breast Cancer|December 21, 2020
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO StudyNicla La Verde, Elena Collovà, Livio Blasi, et al.
Medical Oncology (Northwood, London, England)|April 2, 2017
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumabIcro Meattini, Giuseppe Curigliano, Francesca Terziani, et al.
Pageof 41